Santa Clara, California–based HeartBeam develops a 3D-vector electrocardiogram (ECG) platform for heart attack detection.
The company said in a news release that Fitzgerald joins with “world-renowned” expertise in interventional cardiology. HeartBeam also referred to him as an “accomplished inventor, entrepreneur and investment fund founder.”
“We are thrilled to have Dr. Fitzgerald, one of the world’s preeminent opinion leaders in cardiology and digital health, join the HeartBeam leadership team and play a major role in defining best paths to adoption, clinical strategies, and partnerships to advance our products in the market,” said Branislav Vajdic, founder and CEO of HeartBeam. “In addition to his cardiovascular clinical and research expertise, Dr. Fitzgerald has a rich history of developing successful collaborations with partners in the industry and has developed deep connections across the investment and medical communities.”
About Dr. Peter Fitzgerald
Fitzgerald serves as director of the Center for Cardiovascular Technology and Director of the Cardiovascular Core Analysis Laboratory at Stanford University Medical School. In addition to his experience as an interventional cardiologist, he holds a Ph.D. in electrical engineering.
His accomplishments include being the principal and founder of 24 medical device companies in the San Francisco Bay area. He transitioned 18 startups to medium/large-cap life sciences companies. He founded TriVentures, an incubator/venture fund, in 2009. Additionally, Fitzgerald served as a consultant to the FDA for the last 20 years.
“HeartBeam’s focus on bringing novel diagnostic tools to cardiac patients, especially those with a high risk for a heart attack, could have a significant, positive impact on medical outcomes and quality of life for patients while potentially saving healthcare dollars,” said Fitzgerald. “I look forward to supporting the planned advancement of the company’s rich product pipeline to deliver comprehensive cardiac care for patients anytime, anywhere.”
